Vaccine Advisers Limit Use of Combined Measles, Mumps, Rubella and Chickenpox Vaccine

Strategic Insights -

Advisers to the US Department of Health and Human Services have voted to limit the use of a combination shot that protects against measles, mumps, rubella, and chickenpox. The Advisory Committee on Immunization Practices (ACIP) voted 8-3, with one abstention, to recommend that the combined MMRV vaccine not be given to children under the age of 4. Instead, younger kids will receive separate MMR and varicella (chickenpox) vaccines.

The decision was made to reduce the risk of rare fever-related seizures that can occur in toddlers after the first dose of the combined vaccine. While these seizures do not cause long-term harm, they can be alarming for parents. However, many pediatricians and health leaders have criticized the move, arguing that it will confuse parents and undermine trust in vaccines.

Key Takeaways:

  • The Advisory Committee on Immunization Practices (ACIP) voted 8-3, with one abstention, to limit the use of the combined MMRV vaccine in children under 4 years old.
  • The panel recommended giving separate MMR and varicella (chickenpox) vaccines to younger children to reduce the risk of rare fever-related seizures.
  • Critics argue that the move will confuse parents and undermine trust in vaccines, potentially leading to lower vaccination rates and the resurgence of diseases that have been largely conquered.
  • The decision was influenced by concerns about rare fever-related seizures that can occur in toddlers after the first dose of the combined vaccine.
  • The MMRV vaccine has been extensively studied and has been found to be safe and effective in protecting against measles, mumps, rubella, and chickenpox.
  • Dr. Susan Kressly, president of the American Academy of Pediatrics, warned that the move will lead to chaos and false information among families.
  • Infectious disease expert Mike Osterholm of the University of Minnesota said that the move is "solution looking for a problem" and that combination shots have been used safely for many years.

Statistics:

  • The annual number of infant hepatitis B cases dropped from 5,494 in 2005 to 2,214 in 2023, following the recommendation to vaccinate newborns within 24 hours of birth.
  • The hepatitis B vaccine is up to 95% effective at preventing chronic infection.
  • In the United States, the Centers for Disease Control and Prevention (CDC) has recommended that infants receive a first dose of the hepatitis B vaccine within 24 hours of birth since 2005.
  • The CDC notes that the MMRV vaccine is safe and effective in protecting against measles, mumps, rubella, and chickenpox.

Sources:

  • The Associated Press, Sept. 18, 2025
  • The U.S. Centers for Disease Control and Prevention (CDC) has more on the MMRV vaccine.